(VIANEWS) – NASDAQ Composite ended the session with Xenetic Biosciences (XBIO) rising 9.58% to $4.46 on Monday while NASDAQ Composite rose 0.06% to $14,681.07.
Today’s last reported volume for Xenetic Biosciences is 26994100, 212.24% above its average volume of 8645360.
Xenetic Biosciences’s last close was $4.07, 30.43% below its 52-week high of $5.85.
The company’s growth estimates for the ongoing quarter is a negative 6.7% and positive 85% for the next.
Xenetic Biosciences’s Revenue
Year-on-year quarterly revenue growth grew by 786.7%, now sitting on 436.94k for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Xenetic Biosciences’s stock is considered to be oversold (<=20).
Xenetic Biosciences’s Stock Yearly Top and Bottom Value
Xenetic Biosciences’s stock is valued at $4.46 at 17:18 EST, way under its 52-week high of $5.85 and way above its 52-week low of $0.76.
Xenetic Biosciences’s Moving Average
Xenetic Biosciences’s worth is way higher than its 50-day moving average of $2.10 and way above its 200-day moving average of $2.29.
More news about Xenetic Biosciences (XBIO).